Natural product-based therapy for pulmonary arterial hypertension: I3C, a natural product of Brassica vegetables, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene, 4/February/2015, 22.06

Molecular therapy for Stroke: I3C inhibits cerebral ischemia induced injury via up regulation of its target gene, 4/February/2015, 22.00
February 4, 2015
MiRNA-based Regenerative Stem cell therapy for Myocardial Infarction: MiRNA-3473b improves ageing- and stress-associated decline in cardiac function via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 4/February/2015, 22.18
February 4, 2015
Show all

A study from the University of California, La Jolla, CA, USA shows that Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published in the 15 November  2009 issue of Nature Medicine by Prof. Thistlethwaite PA, Li X and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for pulmonary arterial hypertension: I3C, a natural product of Brassica vegetables, attenuates pulmonary hypertension  inhibits the development of pulmonary arterial hypertension via down regulation of its target gene. Together, pharmacological formulations encompassing “I3C or its analogues may be used to treat pulmonary arterial hypertension.

Amount: $ 500*

Undisclosed information: How Arctigenin  decreases pulmonary arterial hypertension

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Natural product-based therapy for pulmonary arterial hypertension: I3C inhibits the development of pulmonary arterial hypertension via down regulation of its target gene, 4/February/2015,  22.07,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.